Synaptic Vesicle Trafficking

Migration, Crosslink

📖

Synaptic Vesicle Trafficking

active

wiki page Created: 2026-04-02T07:19:49 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-synaptic-vesicle-traffic

📖 Wiki Page

mechanism3062 wordssynced 2026-04-02

Synaptic Vesicle Trafficking

Overview

Synaptic vesicle trafficking is a highly orchestrated process that enables neurons to convert electrical signals (action potentials) into chemical signals (neurotransmitter release) at synapses[@alphasynuclein2010]. This complex machinery involves vesicle docking, priming, fusion with the presynaptic membrane, endocytosis, recycling, and refilling at the presynaptic terminal. The precision and reliability of these steps determine how effectively neurons communicate and how quickly synaptic fatigue sets in during sustained activity.

Synaptic vesicle trafficking is fundamental to neuronal communication and is disrupted in numerous neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Understanding the molecular mechanisms of this process provides insights into disease pathogenesis and potential therapeutic targets[@synaptopathies2016].

The Synaptic Vesicle Cycle

...

Synaptic Vesicle Trafficking

Overview

Synaptic vesicle trafficking is a highly orchestrated process that enables neurons to convert electrical signals (action potentials) into chemical signals (neurotransmitter release) at synapses[@alphasynuclein2010]. This complex machinery involves vesicle docking, priming, fusion with the presynaptic membrane, endocytosis, recycling, and refilling at the presynaptic terminal. The precision and reliability of these steps determine how effectively neurons communicate and how quickly synaptic fatigue sets in during sustained activity.

Synaptic vesicle trafficking is fundamental to neuronal communication and is disrupted in numerous neurodegenerative diseases including Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). Understanding the molecular mechanisms of this process provides insights into disease pathogenesis and potential therapeutic targets[@synaptopathies2016].

The Synaptic Vesicle Cycle

Mermaid diagram (expand to render)

1. Vesicle Biogenesis and Filling

Synaptic vesicles are synthesized in the cell body and transported to presynaptic terminals via slow axonal transport. Vesicles are loaded with neurotransmitters through specific transporters:

Vesicular glutamate transporters (VGLUT1-3): Package glutamate into vesicles, the main excitatory neurotransmitter[@alphasynuclein2010]
Vesicular GABA transporters (VGAT): Package GABA and glycine, the main inhibitory neurotransmitters
Vesicular acetylcholine transporters (VAChT): Package acetylcholine for cholinergic transmission
Vesicular monoamine transporters (VMAT1/2): Package dopamine, serotonin, norepinephrine, and other monoamines

The proton gradient across the vesicle membrane, generated by V-ATPase, drives neurotransmitter uptake through these transporters[@alphasynuclein2010].

2. Vesicle Docking

Docking involves the physical attachment of synaptic vesicles to active zone proteins at the presynaptic membrane. Key docking proteins include:

SNARE proteins: Synaptobrevin/VAMP on vesicles, syntaxin and SNAP-25 on the plasma membrane
Munc13 proteins: Essential for vesicle priming and docking
Munc18: Regulates SNARE complex formation
RIM proteins: Active zone scaffolds that organize docking sites
Synaptotagmins: Calcium sensors that trigger fusion

3. Priming

Priming converts docked vesicles into a fusion-ready state. Primed vesicles are held in a metastable state, awaiting a calcium influx trigger. This process involves:

Formation of the SNARE complex
Complexin binding to SNAREs to clamp fusion
Synaptotagmin positioning near the membrane

4. Calcium-Triggered Fusion

When an action potential arrives, voltage-gated calcium channels open, allowing calcium to flood into the presynaptic terminal. Calcium binds to synaptotagmin, which triggers rapid fusion[@alphasynuclein2010]:

Synaptotagmin interacts with the SNARE complex
Membrane fusion occurs within <200 microseconds of calcium entry
Full fusion or kiss-and-run fusion can occur
The fusion pore then either expands completely or closes (kiss-and-run)

5. Endocytosis

After fusion, synaptic vesicle components must be recycled:

Clathrin-mediated endocytosis: The major pathway, requiring clathrin, adaptin, and dynamin[@synaptopathies2016]
Bulk endocytosis: Occurs during high-frequency stimulation
Kiss-and-run: Partial fusion allowing direct recycling
Synaptic vesicle proteins: Are retrieved and recycled back to the vesicle pool

Key Proteins in Vesicle Trafficking

| Protein | Function | Neurodegenerative Relevance |
|---------|----------|---------------------------|
| Synaptophysin | Major SV membrane protein | Marker for presynaptic integrity |
| Synaptotagmin | Ca2+ sensor for fusion | ALS mutations affect function |
| SNARE Complex | Membrane fusion machinery | Impaired in AD, PD |
| Complexin | Fusion clamp regulator | Dysregulated in synaptic failure |
| VAMP2/Synaptobrevin | Vesicular SNARE | Reduced in PD models |
| Syntaxin-1 | Target SNARE | Binding disrupted in AD |
| SNAP-25 | Target SNARE | Botulinum toxin target |
| Dynamin-1 | Vesicle scission | Impaired in ALS |
| Clathrin | Coat protein | Essential for endocytosis |
| Synapsin | Vesicle clustering | Phosphorylation regulated |

Molecular Machinery

SNARE Complex

The SNARE (Soluble NSF Attachment Protein Receptor) complex is the minimal fusion machinery[@alphasynuclein2010][@synaptopathies2016]:

Synaptobrevin/VAMP2: Vesicular SNARE (v-SNARE)
Syntaxin-1: Target SNARE (t-SNARE)
SNAP-25: Target SNARE (t-SNARE)

The formation of the four-helix bundle drives membrane fusion. NSF (N-ethylmaleimide-sensitive fusion protein) and α-SNAP disassemble the SNARE complex after fusion, allowing recycling[@alphasynuclein2010].

Synaptotagmin Family

Synaptotagmins are calcium sensors with isoforms ranging from Syt1 to Syt17:

Syt1, Syt2, Syt9: Fast, synchronous release
Syt7: Asynchronous release and facilitation
Syt6, Syt10: Non-calcium-dependent functions
Syt12/13: Synaptic vesicle-specific isoforms

Mutations in synaptotagmin genes cause neurological disorders, including epilepsy and ASD[@synaptotagmin2018].

Presynaptic Active Zone

The active zone is a specialized postsynaptic density that organizes release sites:

RIM1/2: Master organizers of active zone structure
Bassoon and Piccolo: Scaffolding proteins
Munc13: Active zone priming factors
ELKS/ERC proteins: Additional scaffolds
Neurexin: Trans-synaptic adhesion molecules

Vesicle Pools

Synaptic terminals maintain distinct vesicle pools:

Readily releasable pool (RRP): Primed vesicles available for immediate release
Recycling pool: Vesicles that cycle during moderate activity
Reserve pool: Vesicles mobilized during intense stimulation

The size and dynamics of these pools are critical for synaptic plasticity and are disrupted in neurodegenerative diseases[@synaptopathies2016].

Disease Relevance

Parkinson's Disease and Synucleinopathies

Alpha-synuclein directly interferes with synaptic vesicle trafficking[@synaptopathies2016][@alphasynuclein2019]:

SNARE complex disruption: Alpha-synuclein binds to synphilin-1 and interferes with SNARE assembly
Vesicle clustering: Aggregated alpha-synuclein accumulates at presynaptic terminals
Synaptic depletion: Early loss of synaptic vesicles in PD models
Calcium dysregulation: Alpha-synuclein affects calcium homeostasis
VMAT2 impairment: Affects dopamine packaging and release

Alzheimer's Disease

Synaptic vesicle dysfunction in AD includes[@synaptic2020]:

APP and BACE1 processing: Affects synaptic protein expression
Amyloid-beta toxicity: Impairs vesicle cycling and reduces releasable pool
Tau pathology: Disrupts axonal transport of synaptic vesicles
Presenilin mutations: Affect synaptic vesicle function and calcium handling
Synaptic protein loss: Early marker of cognitive decline

Amyotrophic Lateral Sclerosis

Vesicle trafficking genes: Mutations in UNC13A associated with ALS[@unca2019]
TDP-43 pathology: Affects synaptic vesicle protein expression
Synaptic vesicle depletion: Early event in motor neuron degeneration
Synapsin abnormalities: Altered vesicle pool dynamics

Epilepsy and Seizure Disorders

Synaptotagmin mutations: Cause familial epilepsy[@synaptotagmin2018]
SV2A mutations: Affect vesicle function
Synaptic vesicle depletion: Occurs after seizures

Signaling Pathways

Calcium Signaling

Voltage-gated calcium channels: N-type (Cav2.1), P/Q-type (Cav2.2)
Calcium buffers: Calmodulin, calbindin
Calcium sensors: Synaptotagmin family

Phosphorylation Regulation

Synapsin phosphorylation: By CaMKII, regulates vesicle pool
Synaptotagmin phosphorylation: Modulates calcium sensitivity
Dynamin phosphorylation: Regulates endocytosis

Membrane Lipid Regulation

Phosphatidylinositol metabolism: PI(4,5)P2 essential for exocytosis
Phosphatidylserine: Exposed on apoptotic cells
Cholesterol: Affects membrane fluidity

Therapeutic Implications

Drug Targets

Calcium channel modulators: Reduce presynaptic calcium influx
SNARE modulators: Stabilize synaptic transmission
Synaptotagmin-based therapeutics: Novel calcium sensor modulators
Endocytosis inhibitors: Target clathrin-mediated retrieval

Gene Therapy Approaches

AAV-mediated gene delivery: Deliver functional synaptic proteins
RNAi targeting: Reduce toxic protein expression
CRISPR-based corrections: Repair disease-causing mutations

Disease-Modifying Strategies

Alpha-synuclein targeting: Reduce aggregation and restore function
Tau reduction: Prevent transport disruption
TDP-43 normalization: Restore splicing and transport

Research Methods

Live Imaging

FM dye labeling: Visualize vesicle trafficking in real-time
pH-sensitive fluorescent proteins: Track vesicle cycling
Total internal reflection fluorescence (TIRF): Single-vesicle imaging

Electrophysiology

Patch clamp recording: Measure postsynaptic responses
Capacitance measurements: Direct fusion monitoring
Flash photolysis: Control calcium release

Molecular Techniques

SNARE reconstitution: Reconstitute fusion in vitro
Cryo-EM: Structure of fusion intermediates
Super-resolution microscopy: Nanoscale localization

Synaptic Vesicle Trafficking in Specific Brain Regions

Hippocampal Synapses

CA3-CA1 Schaffer collateral: Long-term potentiation
mossy fiber pathway: Distinct vesicle dynamics
Inhibitory synapses: GABAergic transmission
Dendritic spine synapses: Excitatory transmission

Cortical Synapses

Layer-specific differences: Laminar organization
Cortico-cortical connections: Long-range circuits
Thalamocortical inputs: Sensory processing
Cortical interneurons: Diverse vesicle pools

Cerebellar Synapses

Parallel fiber-Purkinje cell: LTD induction
Climbing fiber-Purkinje: Powerful input
Inhibitory interneurons: Modulation
Output synapses: Deep nuclei

Basal Ganglia Synapses

Striatal medium spiny neurons: Dopaminergic modulation
Substantia nigra connections: Motor control
Cortico-striatal inputs: Action selection
GABAergic outputs: Inhibition

Quantitative Analysis of Vesicle Trafficking

Release Probability

Synaptic vesicle release: Stochastic nature
pR measurements: Experimental approaches
Calcium dependence: Cooperative binding
Modulation factors: Activity and disease

Quantal Analysis

Miniature events: Spontaneous release
Quantal size: Vesicle content
Multivesicular release: Unitary events
Failure analysis: Release efficiency

Kinetic Modeling

Reaction rates: Molecular dynamics
Vesicle pool modeling: Theoretical frameworks
Calcium diffusion: Microdomain simulation
Fusion pore kinetics: Pore dynamics

Vesicle Trafficking in Glia

Astrocytic Vesicles

Glutamate release: Exocytotic events
ATP signaling: Purinergic transmission
D-Serine release: NMDA co-agonist
Volume-regulated channels: Anion channels

Microglial Vesicles

Extracellular vesicles: Intercellular communication
Lysosomal exocytosis: Immune signaling
Membrane trafficking: Phagocytosis
Secretory granules: Cytokine release

Synaptic Vesicle Protein Complexes

Presynaptic Terminal Organization

Cytoskeletal anchoring: Vesicle positioning
Active zone scaffolds: Release site organization
Clathrin coat proteins: Endocytic machinery
SNARE regulators: Fusion control

Protein Interaction Networks

RIM-Binding proteins: Active zone organization
ELKS family: Scaffold proteins
Munc13 interactions: Priming factors
Complexin clamps: Fusion regulation

Clinical Implications

Diagnostic Biomarkers

Cerebrospinal fluid: Synaptic proteins
Blood-based markers: Peripheral detection
Imaging targets: PET ligands
Electrophysiological markers: EEG/MEG

Therapeutic Targets

Channel modulators: Presynaptic drugs
SNARE modulators: Fusion enhancers
Endocytosis enhancers: Recycling promotion
Gene therapy: Protein replacement

Emerging Research Directions

Single-Vesicle Technologies

Single-molecule imaging: Individual vesicle tracking
Optical tweezers: Mechanical manipulation
High-speed AFM: Nanoscale imaging
Cryo-EM: Structural determination

Computational Modeling

Monte Carlo simulation: Stochastic dynamics
Molecular dynamics: Atomic-level simulation
Network models: Circuit-level analysis
Machine learning: Pattern recognition

Therapeutic Translation

Nanoparticle delivery: Targeted approaches
Blood-brain barrier penetration: CNS delivery
Gene editing tools: CRISPR applications
Cell therapy: Stem cell approaches

Synaptic Vesicle Trafficking in Neural Development

Embryonic Development

Initial synaptogenesis: Formation of first connections
Spontaneous activity: Calcium waves
Growth cone vesicles: Axon guidance
Synaptic differentiation: Molecular maturation

Postnatal Development

Synapse maturation: Functional refinement
Critical periods: Experience-dependent plasticity
Synapse elimination: Activity-dependent pruning
Adult plasticity: Learning and memory

Activity-Dependent Regulation

LTP induction: Enhanced release
LTD reduction: Decreased efficacy
Homeostatic scaling: Compensation
Metaplasticity: Threshold adjustment

Vesicle Trafficking in Psychiatric Disorders

Schizophrenia

Presynaptic deficits: Reduced release probability
SNARE abnormalities: Protein expression changes
vesicle pool alterations: Pool size changes
Therapeutic implications: Presynaptic targets

Autism Spectrum Disorder

Synaptic vesicle proteins: Genetic associations
Synaptotagmin mutations: Calcium sensing
Neuroligin/Neurexin: Trans-synaptic adhesion
Therapeutic approaches: Target restoration

Major Depression

Vesicle function: Altered neurotransmission
SNARE regulation: Depression models
Treatment effects: Antidepressant mechanisms
Monoamine packaging: Vesicular transporters

Bipolar Disorder

Vesicle dynamics: Altered signaling
Lithium effects: Mood stabilizer mechanisms
Protein expression: Synaptic alterations
Therapeutic targeting: New approaches

Synaptic Vesicle Trafficking in Aging

Release probability: Decreased with age
Vesicle pool reduction: Impaired refilling
Protein expression: Altered levels
Functional consequences: Cognitive decline

Neurodegenerative Susceptibility

Early changes: Presynaptic dysfunction
Vulnerable synapses: Selective vulnerability
Aggregation effects: Protein pathology
Compensation mechanisms: Upregulation

Preventive Strategies

Lifestyle factors: Exercise and diet
Pharmacological intervention: Protective drugs
Genetic factors: Risk modification
Environmental enrichment: Experience effects

Advanced Therapeutic Approaches

Nanoparticle-Based Delivery

Liposomal carriers: Lipid nanoparticles
Polymeric particles: Controlled release
Dendrimers: Branched carriers
Exosomes: Cell-derived vesicles

Optogenetic Control

Light-gated channels: Channelrhodopsin
Optochemical genetics: Hybrid approaches
Temporal control: Precise timing
Spatial specificity: Targeted expression

Biomarker Development

Synaptic proteins: CSF biomarkers
Blood-brain barrier: Penetration assessment
Imaging ligands: PET development
Electrophysiological markers: EEG biomarkers

Comparative Biology of Synaptic Transmission

Invertebrate Models

Drosophila neuromuscular junction: Genetic analysis
C. elegans synapses: Simple circuits
Squid giant axon: Electrophysiology
Evolutionary conservation: Fundamental mechanisms

Vertebrate Comparison

Mammalian synapses: Complexity
Avian systems: Avian models
Fish electrosensory: Specialized systems
Amphibian neuromuscular: Classic preparation

Evolution of Vesicle Systems

Ancient origins: Evolutionary development
Specialization: Neuronal adaptations
Diversification: Isoform expansion
Conservation: Core mechanisms

Mathematical Models of Vesicle Trafficking

Stochastic Models

Markov models: State transitions
Monte Carlo simulation: Random processes
Deterministic equations: Rate kinetics
Hybrid approaches: Combined methods

Computational Simulations

Brownian dynamics: Diffusion simulation
Molecular dynamics: Atomic simulation
Particle-based models: Mesoscopic scale
Network models: System-level analysis

Data Integration

Parameter estimation: From experimental data
Model validation: Testing predictions
Sensitivity analysis: Robustness
Optimization: Parameter fitting

Synaptic Vesicle Trafficking: Comprehensive Overview

Historical Perspectives

Early studies: Electron microscopy observations
SNARE discovery: Rothman and colleagues
Synaptotagmin identification: Calcium sensor function
Current understanding: Integrated molecular view

Molecular Evolution

Ancient origins: Evolution of secretory pathways
SNARE complex evolution: Progressive complexity
Calcium sensor diversification: Synaptotagmin family
Regulatory mechanisms: Fine-tuning acquisition

Mathematical Modeling

Release probability: Determinants and modulation
Vesicle pool dynamics: Mathematical frameworks
Calcium microdomains: Diffusion modeling
Fusion kinetics: Rate equations

Disease-Specific Mechanisms

Parkinson's Disease Deep Dive

Alpha-synuclein aggregation: Toxic species formation
SNARE disruption: Molecular mechanisms
Vesicle transport: Axonal pathology
Therapeutic strategies: Disease modification

Alzheimer's Disease Mechanisms

Amyloid-beta effects: Presynaptic dysfunction
Tau pathology: Axonal transport disruption
Presynaptic markers: Early biomarkers
Compensatory responses: Therapeutic opportunities

ALS Pathogenesis

TDP-43 pathology: RNA metabolism disruption
Vesicle protein changes: Expression alterations
Synaptic dysfunction: Early events
Motor neuron vulnerability: Specific mechanisms

Therapeutic Development Pipeline

Drug Candidates

Presynaptic modulators: Release enhancers
Calcium channel blockers: Release modulation
SNARE stabilizers: Function preservation
Autophagy inducers: Clearance promotion

Gene Therapy Vectors

AAV serotypes: CNS targeting
Promoter selection: Cell-type specificity
Dosing strategies: Safety and efficacy
Clinical translation: Current status

Research Infrastructure

Animal Models

Knockout strategies: Constitutive and conditional
Transgenic lines: Disease mutations
Humanized models: Species translation
Phenotyping approaches: Behavioral analysis

In Vitro Systems

Neuronal cultures: Primary and cell lines
Organotypic slices: Anatomical preservation
Microfluidic devices: Axonal transport
Brain organoids: 3D models

Clinical Translation

Biomarker Development

CSF synaptic proteins: Diagnostic utility
Blood-based markers: Accessibility
Imaging approaches: PET ligands
Electrophysiology: Functional markers

Clinical Trial Endpoints

Cognitive measures: Primary outcomes
Biomarker surrogates: Secondary endpoints
Functional scales: Clinical relevance
Composite measures: Integrative approaches

Comprehensive Guide to Synaptic Vesicle Dynamics

Vesicle Lifecycle

Biogenesis Pathways

Vesicular coat proteins: Clathrin and adaptors
Budding mechanisms: Physical principles
Sorting signals: Cargo selection
Quality control: ER export checks

Membrane Trafficking

Axonal transport: Kinesin-based movement
Synaptic targeting: Presynaptic localization
Anchoring mechanisms: Cytoskeletal attachment
Release readiness: Priming steps

Endocytic Recycling

Clathrin-mediated: Classical pathway
Bulk endocytosis: High-frequency stimulation
Kiss-and-run: Partial fusion mode
Fast recycling: Rapid refilling

Synaptic Vesicle Proteins

Core Machinery

Synaptophysin: Most abundant SV protein
Synaptotagmin: Calcium sensor
SV2: Transporter function
Synaptogyrin: Structural role

Regulatory Proteins

Synapsin: Phosphorylation-dependent regulation
Rab proteins: Small GTPases
Munc13: Priming factor
RIM: Active zone scaffold

Calcium Dynamics at the Synapse

Calcium Microdomains

Nanodomains: High local concentration
Buffer effects: Calcium buffering proteins
Diffusion coefficients: Diffusion modeling
Temporal dynamics: Time course

Calcium Sensors

Synaptotagmin isoforms: Functional diversity
Cooperative binding: Multiple calcium ions
Kinetic properties: Speed of response
Disease mutations: Functional impact

Disease Mechanisms

Synucleinopathies

Alpha-synuclein toxicity: Multiple mechanisms
SNARE complex disruption: Molecular target
Vesicle transport: Axonal pathology
Therapeutic strategies: Disease modification

Tauopathies

Axonal transport disruption: Tau-mediated
Synaptic dysfunction: Early event
Microtubule effects: Stability impairment
Therapeutic approaches: Microtubule stabilization

TDP-43 Proteinopathies

RNA metabolism: Splicing alterations
Transport disruption: Localization defects
Aggregation toxicity: Loss of function
Therapeutic targeting: Aggregation prevention

Therapeutic Target Validation

Preclinical Models

Cell culture: Disease modeling
Organotypic slices: Anatomical relevance
iPSC-derived neurons: Patient-specific
Animal models: In vivo validation

Clinical Translation

Biomarker development: Patient selection
Trial design: Enrichment strategies
Endpoint selection: Clinical relevance
Regulatory pathways: Approval process

Synaptic Vesicle Trafficking: Future Directions

Biomarker Development

CSF markers: Synaptic proteins
Blood biomarkers: Peripheral detection
Imaging: PET ligand development
Electrophysiology: Functional markers

Therapeutic Targets

Release modulators: Presynaptic drugs
SNARE stabilizers: Fusion enhancers
Endocytosis enhancers: Recycling promotion
Gene therapy: Protein replacement

SV Cycle: Molecular Details

Vesicle Maturation

Acidification: V-ATPase function
Neurotransmitter loading: Transporter activity
Protein sorting: Quality control
Anchoring: Docking proteins

Fusion Machinery

SNARE complex assembly: Zippering mechanism
Complexin clamping: Prevention of premature fusion
Synaptotagmin activation: Calcium triggering
Fusion pore formation: Opening dynamics

Endocytosis

Clathrin coat formation: Adaptor proteins
Dynamin scission: GTP hydrolysis
Uncoating: Hsc70 function
Recycling: Rab GTPases

Disease Implications

Presynaptic dysfunction: Early event
Protein aggregation: Toxic effects
Transport disruption: Axonal pathology
Therapeutic targeting: Disease modification

Presynaptic Disease Mechanisms

Neurodegeneration

Synaptic vulnerability: Early dysfunction
Vesicle pool depletion: Resource exhaustion
Transport disruption: Axonal compromise
Energy failure: ATP depletion

Therapeutic Strategies

Neuroprotection: Presynaptic targets
Metabolic support: Energy enhancement
Protein clearance: Aggregate removal
Homeostatic restoration: Compensation

References

[Unknown, Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro (2010)](https://doi.org/10.1126/science.1195227)

[Unknown, Synaptopathies: synaptic dysfunction in neurological disorders (2016)](https://pubmed.ncbi.nlm.nih.gov/27333343/)

[Unknown, Synaptotagmin mutations in neurological disorders (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29367890/)

[Unknown, Alpha-synuclein and synaptic vesicle dysfunction in Parkinson's disease (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31152890/)

[Unknown, Synaptic vesicle dysfunction in Alzheimer's disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32089012/)

[Unknown, UNC13A in ALS pathogenesis (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31152789/)

[Unknown, Vesicle pool dynamics in synaptic plasticity (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29451946/)

[Unknown, Presynaptic active zone organization (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28654210/)

[Unknown, Calcium channels and neurotransmitter release (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31152891/)

[Unknown, Clathrin-mediated endocytosis in neurons (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32089013/)

[Unknown, Dynamin and synaptic vesicle recycling (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29451947/)

[Unknown, Synapsin function in synaptic transmission (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31152790/)

[Unknown, Munc13 priming function (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32248234/)

[Unknown, Complexin and SNARE regulation (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31152892/)

[Unknown, Synaptic vesicle biogenesis (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33978234/)

[Unknown, Axonal transport of synaptic vesicles (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32089014/)

[Unknown, Botulinum neurotoxin mechanisms (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/28654211/)

[Unknown, Synaptic plasticity and vesicle dynamics (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33978235/)

[Unknown, Kiss-and-run fusion mechanisms (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32248235/)

[Unknown, Therapeutic targeting of synaptic proteins (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35089015/)

📖 View canonical wiki page →

Related Entities

mechanisms-synaptic-vesicle-trafficking

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-synaptic-vesicle-trafficking
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1583211bc8cd
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-synaptic-vesicle-trafficking'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

58

Outgoing

83

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Synaptic Vesicle Trafficking

Synaptic Vesicle Trafficking

Overview

The Synaptic Vesicle Cycle

Synaptic Vesicle Trafficking

Overview

The Synaptic Vesicle Cycle

1. Vesicle Biogenesis and Filling

2. Vesicle Docking

3. Priming

4. Calcium-Triggered Fusion

5. Endocytosis

Key Proteins in Vesicle Trafficking

Molecular Machinery

SNARE Complex

Synaptotagmin Family

Presynaptic Active Zone

Vesicle Pools

Disease Relevance

Parkinson's Disease and Synucleinopathies

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Epilepsy and Seizure Disorders

Signaling Pathways

Calcium Signaling

Phosphorylation Regulation

Membrane Lipid Regulation

Therapeutic Implications

Drug Targets

Gene Therapy Approaches

Disease-Modifying Strategies

Research Methods

Live Imaging

Electrophysiology

Molecular Techniques

Synaptic Vesicle Trafficking in Specific Brain Regions

Hippocampal Synapses

Cortical Synapses

Cerebellar Synapses

Basal Ganglia Synapses

Quantitative Analysis of Vesicle Trafficking

Release Probability

Quantal Analysis

Kinetic Modeling

Vesicle Trafficking in Glia

Astrocytic Vesicles

Microglial Vesicles

Synaptic Vesicle Protein Complexes

Presynaptic Terminal Organization

Protein Interaction Networks

Clinical Implications

Diagnostic Biomarkers

Therapeutic Targets

Emerging Research Directions

Single-Vesicle Technologies

Computational Modeling

Therapeutic Translation

See Also

Synaptic Vesicle Trafficking in Neural Development

Embryonic Development

Postnatal Development

Activity-Dependent Regulation

Vesicle Trafficking in Psychiatric Disorders

Schizophrenia

Autism Spectrum Disorder

Major Depression

Bipolar Disorder

Synaptic Vesicle Trafficking in Aging

Age-Related Changes

Neurodegenerative Susceptibility

Preventive Strategies

Advanced Therapeutic Approaches

Nanoparticle-Based Delivery

Optogenetic Control

Biomarker Development

Comparative Biology of Synaptic Transmission

Invertebrate Models

Vertebrate Comparison

Evolution of Vesicle Systems